Vahanian & Associates Financial Planning’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	$286K	Buy	+4,575	New	+$286K	1.13%	31